Atlas Trials

To Test the Potential Efficacy of Repeated Intranasal Administration of Ketamine as a Treatment for PTSD

Clinical trial NCT02398136 · WITHDRAWN

Trial details

NCT number
NCT02398136
Sponsor
Adriana Feder
Status
WITHDRAWN
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
PTSD
Start date
2014-12-01
Primary completion
2014-12-01
Enrollment
0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.